BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 18509804)

  • 21. Longer virus shedding in influenza B than in influenza A among outpatients treated with oseltamivir.
    Kawai N; Ikematsu H; Iwaki N; Kawashima T; Maeda T; Mitsuoka S; Kondou K; Satoh I; Miyachi K; Yamaga S; Shigematsu T; Hirotsu N; Kashiwagi S
    J Infect; 2007 Sep; 55(3):267-72. PubMed ID: 17604839
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [New diagnostic possibilities and medications. Fit for influenza?].
    Wutzler P
    MMW Fortschr Med; 2002 Nov; 144(48):18. PubMed ID: 12532540
    [No Abstract]   [Full Text] [Related]  

  • 23. [Neuraminidase inhibitors in therapy of influenza].
    Fladerer P; Wenisch C
    Acta Med Austriaca; 2000; 27(5):133-40. PubMed ID: 11261262
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel neuraminidase deletion mutation conferring resistance to oseltamivir in clinical influenza A/H3N2 virus.
    Abed Y; Baz M; Boivin G
    J Infect Dis; 2009 Jan; 199(2):180-3. PubMed ID: 19046066
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuraminidase inhibitors--the story behind the Cochrane review.
    Doshi P
    BMJ; 2009 Dec; 339():b5164. PubMed ID: 19995813
    [No Abstract]   [Full Text] [Related]  

  • 26. Neuraminidase inhibitors for influenza treatment and prevention in healthy adults.
    Cayley WE
    Am Fam Physician; 2010 Aug; 82(3):242-4. PubMed ID: 20672786
    [No Abstract]   [Full Text] [Related]  

  • 27. Clinical effectiveness of oseltamivir for influenza A(H1N1) virus with H274Y neuraminidase mutation.
    Kawai N; Ikematsu H; Iwaki N; Kondou K; Hirotsu N; Kawashima T; Maeda T; Tanaka O; Doniwa K; Kashiwagi S
    J Infect; 2009 Sep; 59(3):207-12. PubMed ID: 19619898
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antivirals and influenza: frequency of resistance.
    Monto AS
    Pediatr Infect Dis J; 2008 Oct; 27(10 Suppl):S110-2. PubMed ID: 18820569
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Antiviral treatment of influenza in humans].
    NĂ¼esch R
    Ther Umsch; 2007 Nov; 64(11):635-41. PubMed ID: 18581908
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The threatening influenza pandemic: a national store ofoseltamivir is a waste of money].
    Bonneux L
    Ned Tijdschr Geneeskd; 2005 Jul; 149(29):1619. PubMed ID: 16078769
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Resistance to anti-influenza drugs: adamantanes and neuraminidase inhibitors.
    Hurt AC; Ho HT; Barr I
    Expert Rev Anti Infect Ther; 2006 Oct; 4(5):795-805. PubMed ID: 17140356
    [TBL] [Abstract][Full Text] [Related]  

  • 32. More resistance to oseltamivir (Tamiflu).
    Med Lett Drugs Ther; 2009 Jan; 51(1304):5-6. PubMed ID: 19172138
    [No Abstract]   [Full Text] [Related]  

  • 33. [Controversies about neuraminidase inhibitor. Is the influenza drug less effective than assumed?].
    Haas W
    MMW Fortschr Med; 2010 Jan; 152(3):7. PubMed ID: 20333956
    [No Abstract]   [Full Text] [Related]  

  • 34. Neuraminidase inhibitors for treatment of human and avian strain influenza: A comparative modeling study.
    Dobrovolny HM; Gieschke R; Davies BE; Jumbe NL; Beauchemin CA
    J Theor Biol; 2011 Jan; 269(1):234-44. PubMed ID: 20970433
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oseltamivir for influenza.
    Drug Ther Bull; 2002 Dec; 40(12):89-91. PubMed ID: 12613182
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antiviral treatment for patients hospitalized with 2009 pandemic influenza A (H1N1).
    Uyeki T
    N Engl J Med; 2009 Dec; 361(23):e110. PubMed ID: 19923564
    [No Abstract]   [Full Text] [Related]  

  • 37. [Antiviral agents in influenza--current recommendations. Anti-influenza agents are not a substitution for but a complement to vaccination].
    Uhnoo I; Linde A
    Lakartidningen; 2005 Dec 5-11; 102(49):3802-3, 3805-6, 3808. PubMed ID: 16408704
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Roche perspectives on Tamiflu.
    Clinch B; Smith J
    Clin Microbiol Infect; 2015 Mar; 21(3):226-9. PubMed ID: 25716982
    [No Abstract]   [Full Text] [Related]  

  • 39. Influenza--the case for combination therapy.
    Krystal MR; Meanwell NA
    Curr Opin Investig Drugs; 2009 Aug; 10(8):746-9. PubMed ID: 19649919
    [No Abstract]   [Full Text] [Related]  

  • 40. Assay to detect H5N1 oseltamivir resistance.
    Suwannakarn K; Chutinimitkul S; Payungporn S; Chieochansin T; Theamboonlers A; Amonsin A; Damrongwatanapokin S; Mai le Q; Hanh NH; Poovorawan Y
    Emerg Infect Dis; 2006 Dec; 12(12):1995-6. PubMed ID: 17354342
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.